One more thing: GHK-Cu is an investigational research compound
Rather than waiting and hoping the skin catches up on its own, there is now substantial research suggesting that targeted peptide therapy can actively accelerate the skin remodeling process from the inside out
The causes can be broadly categorised into exogenous (external) and endogenous (internal) factors, with the latter being of greater clinical significance
The FDA recently approved one of these, elamipretide, for the treatment of a rare genetic mitochondrial disorder
That multiple-withdrawal capability reduces experimental variability, protects experimental integrity, and keeps reconstituted lyophilized peptides usable across a full research session rather than a single sitting
This method can be particularly potent because it ensures that the skin receives a consistent dose of the ingredient, maximizing its efficacy